Gesval
Liègegesval.be
Overview
Gesval is the technology transfer and investment firm of the University of Liège and the CHU de Liège, focused on commercializing university research by managing intellectual property and investing in spin-off companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Catalya | Jun 2026 | Seed | Co-investor |
| Ampacimon | Oct 2023 | Series C | Co-investor |
| THERAtRAME | Sep 2022 | Seed | Co-investor |
| Ampacimon | Aug 2020 | Series A | Co-investor |
| Trasis SA | Jun 2004 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?